Establishing Multidisciplinary Clinical Pathways for Proactive, Individualized Treatment of Inflammatory Bowel Disease

Train the Trainer

Despite advances and the availability of different therapies for the treatment of IBD, many patients never achieve or maintain remission and/or are dissatisfied with aspects of their therapy. Selecting, intensifying, sequencing, or combining therapies in IBD can be challenging for clinicians, especially considering the number of novel targeted therapies available and the expanding role of patient-reported outcomes in individualization of therapeutic decision-making. In addition, the care paradigm has evolved to include treat-to-target (T2T) strategies and, most recently, time-dependent treatment targets.

However, gastroenterologists report a myriad of barriers in adopting T2T strategies in routine clinical practice. Some are resource driven, with greater constraints in monitoring experienced by smaller clinical practices, but others are an absence of risk factors for patient stratification or prognostic criteria to inform treatment selection.

As the prevalence of IBD continues to increase, gastroenterology teams must continually assess and adapt to evolving therapeutic strategies to ensure proactive, targeted, and patient-centric treatment to improve outcomes. To support translation and implementation of the latest recommendations into routine clinical practice, this training program, modeled on the CDC Training of Trainers approach, provides learners with the tools and resources to facilitate peer-to-peer learning with their interprofessional clinical teams.

Faculty: Russell D. Cohen, MD, FACG, AGAF, David Choi, PharmD, BCACP

Release Date: June 13, 2025

Expiration Date: June 13, 2026